Journal of Hepatology
Volume 42, Issue 1 , Pages 117-123 , January 2005

Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice

  • Hiroaki Okuyama

      Affiliations

    • Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Hajime Nakamura

      Affiliations

    • Department of Experimental Therapeutics, Translational Research Center, Kyoto University, Kyoto, Japan
    • ,
  • Yasuyuki Shimahara

      Affiliations

    • Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Naoki Uyama

      Affiliations

    • Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Yong-Won Kwon

      Affiliations

    • Department of Biological Responses, Laboratory of Infection and Prevention, Institute for Virus Research, Kyoto University, 53, Shogoin, Kawahara-cho, Sakyo-ku, Kyoto 606-8505, Japan
    • ,
  • Norifumi Kawada

      Affiliations

    • Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan
    • ,
  • Yoshio Yamaoka

      Affiliations

    • Department of Gastroenterological Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Junji Yodoi

      Affiliations

    • Department of Biological Responses, Laboratory of Infection and Prevention, Institute for Virus Research, Kyoto University, 53, Shogoin, Kawahara-cho, Sakyo-ku, Kyoto 606-8505, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 75 751 4024; fax: +81 75 761 5766.

Received 2 May 2004 ,Revised 9 September 2004 ,Accepted 21 September 2004.

References 

  1. Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, et al. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology. 1997;25:368–378
  2. Lieber CS. Alcohol and hepatitis C. Alcohol Res Health. 2001;25:245–254
  3. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993;328:1828–1835
  4. Okuyama H, Shimahara Y, Kawada N. The hepatic stellate cell in the post-genomic era. Histol Histopathol. 2002;17:487–495
  5. Bruck R, Hussein A, Schey R, Matas Z, Reifen R, Zaiger G, et al. Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol. 2002;36:370–377
  6. Okuyama H, Shimahara Y, Kawada N, Seki S, Kristensen DB, Yoshizato K, et al. Regulation of cell growth by redox-mediated extracellular proteolysis of platelet-derived growth factor receptor β. J Biol Chem. 2001;276:28274–28280
  7. Holmgren A. Thioredoxin. Annu Rev Biochem. 1985;54:237–271
  8. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 1989;8:757–764
  9. Yodoi J, Tursz T. ADF: a growth-promoting factor derived from adult T-cell leukemia and homologous to thioredoxin; involvement in lymphocyte immortalization by HTLV-I and EBV. Adv Cancer Res. 1991;57:381–411
  10. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, et al. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA. 1999;96:4131–4136
  11. Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S, et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal. 2002;4:693–696
  12. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, et al. Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med. 1998;188:1445–1451
  13. Nakamura H, Masutani H, Yodoi J. Redox imbalance and its control in HIV infection. Antioxid Redox Signal. 2002;4:455–464
  14. Nakamura H, Tamura S, Watanabe I, Iwasaki T, Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett. 2002;82:165–170
  15. Nishinaka Y, Nakamura H, Okada N, Okada H, Yodoi J. Redox control of EBV infection: prevention by thiol-dependent modulation of functional CD21/EBV receptor expression. Antioxid Redox Signal. 2001;3:1075–1087
  16. Tagaya Y, Wakasugi H, Masutani H, Nakamura H, Iwata S, Mitsui A, et al. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction. Mol Immunol. 1990;27:1279–1289
  17. Okuyama H, Nakamura H, Shimahara Y, Araya S, Kawada N, Yamaoka Y, et al. Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology. 2003;37:1015–1025
  18. Hirota K, Nakamura H, Arai T, Ishii H, Bai J, Itoh T, et al. Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes. Biochem Biophys Res Commun. 2000;275:825–830
  19. Kondo N, Ishii Y, Kwon YW, Tanito M, Horita H, Nishinaka Y, et al. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol. 2004;172:442–448
  20. Tsutsui T, Koide H, Fukahori H, Isoda K, Higashiyama S, Maeda I, et al. Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem Biophys Res Commun. 2003;307:765–770
  21. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, et al. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem. 1999;274:35809–35815
  22. Takeuchi J, Hirota K, Itoh T, Shinkura R, Kitada K, Yodoi J, et al. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Antioxid Redox Signal. 2000;2:83–92
  23. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA. 1997;94:3633–3638
  24. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. J Biol Chem. 1999;274:27891–27897
  25. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, et al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci USA. 2001;98:15143–15148
  26. Chojkier M, Houglum K, Lee KS, Buck M. Long- and short-term d-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression. Am J Physiol. 1998;275:G1480–G1485
  27. Matsumoto K, Masutani H, Nishiyama A, Hashimoto S, Gon Y, Horie T, et al. C-propeptide region of human pro α 1 type 1 collagen interacts with thioredoxin. Biochem Biophys Res Commun. 2002;295:663–667
  28. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol. 2000;33:616–622

PII: S0168-8278(04)00430-1

doi: 10.1016/j.jhep.2004.09.020

Journal of Hepatology
Volume 42, Issue 1 , Pages 117-123 , January 2005

Article Tools

* Image Usage & Resolution